Meningococcal group B vaccine 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 mg/ML Prefilled Syringe [Bexsero]
RxNorm 1601409
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1601409 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: meningococcal group B vaccine 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 mg/ML Prefilled Syringe [Bexsero].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.